USPTO serial 79410960
ROHTO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 10, 2026
- Examiner
- CONNERS,LAUREN G
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ROHTO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kathleen S. Ryan
Kathleen S. Ryan The Ollila Law Group LLC2569 Park Lane, Suite 202Lafayette, CO 80026United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Antistatic preparations for household purposes; de-greasing preparations for household purposes; rust removing preparations; stain removing benzine; fabric softeners for laundry use; laundry bleach; adhesives for affixing false hair; laundry starch; seaweed gelatine for laundry use (funori); adhesives for affixing false eyelashes; breath freshening preparations for personal hygiene; deodorants for animals; paint stripping preparations; shoe cream; shoe black being shoe polish; nonmedicated soaps and detergents for household use; dentifrices; cosmetics; perfumes and flavourings for beverages being essential oils; perfumes and food flavourings being essential oils; incense; false nails; false eyelashes | ACTIVE | — |
| 005 | Pharmaceutical preparations being ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for treatment of eye disease; pharmaceutical preparations for use in eye injections; pharmaceutical preparations for treatment of pinguecula ; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Analgesics; antipyretic preparations; antibiotics; athletes' foot preparations; medicinal drinks; medicinal hair growth preparations; motion sickness treatment preparations; pharmaceutical preparations for treating diabetes; preparations for treating colds; pharmaceutical preparations, namely, astringents, anti-inflammatory liquid for external use, hypnotic sedatives, antipyretic analgesics, anti-cough drops, and vitamin preparations; reagent paper for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; dental impression materials; baby diapers; adult diapers; baby diaper covers; adult diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for human beings; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; semen for artificial insemination; stem cells for medical, pharmaceutical or veterinary use; stem cells for regenerative medicine, medicine or veterinary use; stem cells only for medical and veterinary use; diagnostic reagents for medical clinic or medical laboratory use; diagnostic media for bacteriological cultures for medical purposes or veterinary purposes; microorganism culture media for cultivating human cells, human tissues, animal cells, animal tissues, plant cells, plant tissues and microorganism cells, for medical use; cell culture media for medical or veterinary use; pharmaceutical serums made from blood for medical or veterinary use for promoting tissue regeneration and stimulating cell proliferation; pharmaceutical serums made from blood for medical or veterinary use for inducing cell repair; pharmaceutical serums made from blood for medical or veterinary use in regenerative medicine; pharmaceutical serums made from blood for medical or veterinary use in regenerative medicine for promoting tissue regeneration, stimulating cell proliferation, and inducing cell repair; serums made from blood for diagnostic purposes; immunological serums made from blood for medical treatment of cartilage defects, skin wounds, and internal organ diseases; serum made from blood for cell culture; pharmaceutical preparations comprising blood-derived antibodies for use in serotherapy; fumigants only for agricultural purposes; fungicides only for agricultural purposes; rodenticides only for agricultural purposes; insecticides only for agricultural purposes; herbicides being weedkillers; insect-repellents only for agricultural purposes; antiseptics only for agricultural purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Rohto Pharmaceutical Co., Ltd.
- Other trademarks owned by Rohto Pharmaceutical Co., Ltd.
- Other trademarks owned by Rohto Pharmaceutical Co., Ltd.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named ROHTO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 17, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 17, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 14, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 10, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 27, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 27, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 10, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 10, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 23, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 23, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 17, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 26, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 25, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 25, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 25, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 25, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 27, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 27, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 27, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 27, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 8, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 8, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 12, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 12, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 30, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 29, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 17, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 11, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 11, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 11, 2024 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 28, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |